Author:
Dash Nihar Ranjan,Barqawi Hiba Jawdat,Obaideen Anas A.,Al Chame Hanae Qousae,Samara Kamel A.,Qadri Rama,Eldesouki Salma
Abstract
Abstract
Background
Despite significant efforts to contain the Coronavirus Disease 2019 (COVID-19) pandemic through mass vaccination, numerous nations throughout the world have recorded breakout infections. The incidence and severity of COVID-19 breakthrough infections in the United Arab Emirates (UAE) remain unknown despite extensive COVID-19 vaccine coverage. The goal of this research is to establish the characteristics of COVID-19 breakthrough infections in the UAE’s vaccinated population.
Methods
Between February and March 2022, we conducted a descriptive cross-sectional study in the UAE with 1533 participants to examine the characteristics of COVID-19 breakthrough infection among the vaccinated population.
Results
The vaccination coverage was 97.97%, and the COVID-19 breakthrough infection rate was 32.1%, requiring hospitalization in 7.7% of cases. The bulk of the 492 COVID-19 breakthrough infections reported was among young adults (67%), with the majority experiencing mild to moderate symptoms (70.7%) or remaining asymptomatic (21.5%).
Conclusions
COVID-19 breakthrough infection were reported in younger age, male sex, non-healthcare professions, vaccination with inactivated whole virus vaccine (Sinopharm), and not receiving a booster dose. Information on breakthrough infection in the UAE might influence public health decisions and motivate measures such as providing additional booster doses of the vaccines to the people.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Suliman DM, Nawaz FA, Mohanan P, Modber MAKA, Musa MK, Musa MB, et al. UAE efforts in promoting COVID-19 vaccination and building vaccine confidence. Vaccine. 2021;39(43):6341–5.
2. Hosani FIA, Stanciole AE, Aden B, Timoshkin A, Najim O, Zaher WA, et al. (2021) Sinopharm’s BBIBP-CorV vaccine effectiveness on preventing hospital admission and deaths: results from a retrospective study in the Emirate of Abu Dhabi, United Arab Emirates (UAE). United Arab Emirates (UAE)
3. Pfizer-BioNTech COVID-19 Vaccines. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccines. Accessed 14 Feb 2022.
4. CORONAVIRUS (COVID-19) UPDATES U. Available from: https://covid19.ncema.gov.ae/en. Accessed 23 May 2022
5. Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29.